News



Back


16/11/2017
Kurma Partners announces the successful IPO of Orphazyme.
Kurma Partners announces the successful IPO of Orphazyme, a leading company in rare diseases which raises €80M on Nasdaq Copenhagen [....]

Download the pdf file







FOLLOW US



contact@kurmapartners.com

Tél: +33 (0)1 84 86 08 61

24, rue Royale
75008 Paris
France

© Copyright KURMA PARTNERS.       LEGAL NOTICE       Terms and conditions       REGULATORY INFORMATION     PRIVATE POLICY     Design : AGENCE K2

X

X